
Shares of Klotho Neurosciences, Inc. (NASDAQ:KLTO) have soared more than 1000% over the past three months on promising results and breakthrough hopes. Klotho stock was in the spotlight again Thursday after announcing an FDA nod on its ALS treatment candidate.